by John Conrad | Aug 20, 2024 | NewsBrief
According to PitchBook’s latest Emerging Tech Research report on the medtech industry, the sector is showing resilience and growth despite recent market challenges. The report highlights the successful IPO of precision medicine company Tempus in June 2024 as a...
by John Conrad | Jun 14, 2024 | NewsBrief
Congratulations to iBIO member Tempus AI and its founder, Eric Lefkofsky, on their remarkable achievement! We are thrilled to announce that Tempus AI, a trailblazing precision-medicine startup, is set to make its highly anticipated debut on the stock market this...
by John Conrad | Jan 31, 2020 | Member News
What happens when a highly interdisciplinary and integrated team of scientists, business leaders and students work together across fields of fundamental science, discovery, development, and finance? In the case of Monopar Therapeutics, a Chemistry of Life Processes...
